HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenichi Watanabe Selected Research

Torsemide (Demadex)

10/2017Comparative evaluation of torasemide and spironolactone on adverse cardiac remodeling in a rat model of dilated cardiomyopathy.
3/2017Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy.
8/2014Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy.
7/2009[Effects of various diuretics on cardiac function in rats with heart failure].
2/2008Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.
2/2008Comparative effects of torasemide and furosemide in rats with heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenichi Watanabe Research Topics

Disease

51Fibrosis (Cirrhosis)
01/2022 - 04/2002
45Heart Failure
01/2022 - 04/2002
42Myocarditis (Carditis)
01/2018 - 01/2002
30Inflammation (Inflammations)
01/2021 - 01/2002
26Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
10/2017 - 01/2002
21Hypertrophy
01/2021 - 01/2003
18Body Weight (Weight, Body)
02/2017 - 01/2002
14Neoplasms (Cancer)
07/2021 - 11/2002
13Breast Neoplasms (Breast Cancer)
07/2021 - 02/2004
11Colitis
01/2021 - 07/2007
9Diabetic Cardiomyopathies
01/2018 - 06/2005
9Left Ventricular Dysfunction
10/2012 - 09/2004
8Diabetic Nephropathies (Diabetic Nephropathy)
08/2014 - 05/2011
7Atopic Dermatitis (Atopic Eczema)
01/2018 - 12/2014
7Hyperglycemia
02/2017 - 05/2008
7Cardiomegaly (Heart Hypertrophy)
04/2015 - 02/2005
7Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2009 - 04/2006
6Ischemia
01/2021 - 02/2004
6Diabetes Mellitus
11/2017 - 09/2009
6Cardiotoxicity
01/2012 - 06/2006
5Infections
08/2022 - 01/2006
5Dermatitis
12/2018 - 12/2014
5Cardiovascular Diseases (Cardiovascular Disease)
06/2016 - 04/2006
4Neoplasm Metastasis (Metastasis)
07/2021 - 10/2004
4Hypoglycemia (Reactive Hypoglycemia)
01/2020 - 09/2014
4Proteinuria
09/2013 - 08/2009
3Dementia (Dementias)
03/2022 - 09/2011
3Amyloidosis
01/2021 - 06/2019
3Wounds and Injuries (Trauma)
12/2018 - 03/2007
3Edema (Dropsy)
10/2017 - 10/2010
3Obesity
02/2017 - 11/2005
3Myocardial Infarction
01/2016 - 06/2005
3Brain Ischemia (Cerebral Ischemia)
06/2015 - 04/2006

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2006
18CollagenIBA
01/2016 - 09/2003
14CytokinesIBA
01/2016 - 01/2002
14Messenger RNA (mRNA)IBA
01/2016 - 01/2003
13CurcuminIBA
08/2017 - 01/2011
13Atrial Natriuretic Factor (ANF)IBA
07/2015 - 01/2003
12Cardiac MyosinsIBA
10/2017 - 01/2003
11Streptozocin (Streptozotocin)FDA Link
04/2015 - 06/2005
10AntioxidantsIBA
01/2020 - 04/2006
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2018 - 02/2010
8Angiotensin IIIBA
04/2016 - 02/2004
8Daunorubicin (Cerubidine)FDA LinkGeneric
01/2016 - 06/2006
8InterleukinsIBA
10/2015 - 12/2004
8Telmisartan (Micardis)FDA Link
08/2015 - 07/2010
8Transforming Growth Factor beta1 (TGF beta 1)IBA
07/2015 - 09/2004
8AngiotensinsIBA
10/2012 - 12/2003
8Myosins (Myosin)IBA
07/2012 - 10/2007
7Pharmaceutical PreparationsIBA
04/2022 - 02/2002
7DiureticsIBA
10/2017 - 06/2006
7Angiotensin Receptor AntagonistsIBA
08/2015 - 01/2003
7Carvedilol (Coreg)FDA LinkGeneric
06/2015 - 04/2002
7olmesartanIBA
02/2014 - 11/2010
7Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2011 - 01/2003
6C-Reactive ProteinIBA
01/2021 - 04/2006
6Glucose (Dextrose)FDA LinkGeneric
01/2020 - 04/2006
6Torsemide (Demadex)FDA LinkGeneric
10/2017 - 02/2008
6Dextran SulfateIBA
02/2017 - 02/2010
5Interleukin-6 (Interleukin 6)IBA
10/2021 - 01/2011
5AnthracyclinesIBA
07/2021 - 06/2006
5Amyloid (Amyloid Fibrils)IBA
01/2021 - 01/2015
5EdaravoneIBA
01/2019 - 04/2006
5CalciumIBA
02/2018 - 08/2003
5AntigensIBA
02/2018 - 08/2002
5Fatty Acids (Saturated Fatty Acids)IBA
01/2018 - 01/2002
5Furosemide (Lasix)FDA LinkGeneric
03/2017 - 02/2008
5EnzymesIBA
01/2016 - 02/2003
5ChemokinesIBA
05/2012 - 12/2004
514-3-3 Proteins (14-3-3 Protein)IBA
01/2011 - 06/2005
5Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
10/2010 - 02/2008
4Therapeutic UsesIBA
03/2017 - 07/2007
4Small Interfering RNA (siRNA)IBA
02/2017 - 07/2015
4p38 Mitogen-Activated Protein KinasesIBA
07/2016 - 04/2006
4Receptor for Advanced Glycation End ProductsIBA
06/2015 - 03/2012
4Angiotensin II Type 1 Receptor BlockersIBA
02/2011 - 01/2003
4CholesterolIBA
10/2008 - 06/2005
4Quinapril (Accupril)FDA LinkGeneric
07/2004 - 02/2002
3Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2016
3eribulinFDA Link
07/2021 - 10/2020
3LipidsIBA
01/2021 - 05/2009
3Hormones (Hormone)IBA
09/2020 - 01/2005
3Insulin (Novolin)FDA Link
01/2020 - 09/2014
3Hematoxylin (Haematoxylon)IBA
01/2020 - 03/2012
3Eosine Yellowish-(YS) (Eosin)IBA
01/2020 - 03/2012
3HMGB1 Protein (HMG1)IBA
01/2018 - 12/2014
3Caspase 3 (Caspase-3)IBA
02/2017 - 05/2002
3CarbohydratesIBA
02/2017 - 07/2015
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
06/2016 - 11/2005
3Blood Glucose (Blood Sugar)IBA
05/2016 - 06/2011
3QuercetinIBA
04/2016 - 02/2012
3NitrogenIBA
09/2013 - 06/2011
3Urea (Carbamide)FDA LinkGeneric
09/2013 - 06/2011
3CreatinineIBA
09/2013 - 06/2011
3Triglycerides (Triacylglycerol)IBA
05/2013 - 10/2007
3Calcium Channel Blockers (Blockers, Calcium Channel)IBA
10/2012 - 09/2004

Therapy/Procedure

24Therapeutics
01/2022 - 02/2004
7Drug Therapy (Chemotherapy)
12/2021 - 06/2006
4Oral Administration
01/2005 - 04/2002